A reconciliation of the applicable numerators and denominators of the income statement periods presented, as reflected in the results of continuing operations, is as follows (in thousands, except per share amounts):

 

    Three Months Ended     Three Months Ended     Six Months Ended     Six Months Ended  
    June 30, 2016     June 30, 2015     June 30, 2016     June 30, 2015  
    Loss     Shares     EPS     Loss     Shares     EPS     Loss     Shares     EPS     Loss     Shares     EPS  
Basic loss per share   $ (1,127 )     17,081     $ (0.06 )   $ (1,566 )     16,020     $ (0.10 )   $ (2,463 )     17,081     $ (0.14 )   $ (2,946 )     15,956     $ (0.18 )
                                                                                                 
Dilutives:                                                                                                
Options     -       -       -       -       -       -       -       -       -       -       -       -  
                                                                                                 
Diluted loss per share   $ (1,127 )     17,081     $ (0.06 )   $ (1,566 )     16,020     $ (0.10 )   $ (2,463 )     17,081     $ (0.14 )   $ (2,946 )     15,956     $ (0.18 )

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!

Other recent filings from the company include the following:

BML Investment Partners, L.P. just provided an update on share ownership of ProPhase Labs - Jan. 30, 2018
ProPhase Labs's Chief Accounting Officer just declared owning 7,428 shares of ProPhase Labs - Jan. 23, 2018

Auto Refresh

Feedback